What does IMVT's EPS forecast for Q4 2025 suggest?
4/7/2025 08:37pm
Immunovant's (IMVT) EPS forecast for Q4 2025 suggests a negative outlook for the company. The estimated EPS for the period is -$0.72, indicating a potential loss for the quarter. This negative forecast could be a result of various factors such as market conditions, company performance, or industry trends. Investors often use EPS forecasts to assess the profitability and valuation of a company's stock, so a negative forecast like this could influence investor sentiment.